Bibliographic Details
| Title: |
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes. |
| Authors: |
Kurbatova EV, Whitworth WC, Peddareddy LP, Phillips PPJ, Scott NA, Bryant KE, Dawson R, Cardoso SW, Samaneka W, Engle M, Waja Z, Sizemore E, Carr W, Dooley KE, Savic R, Swindells S, Chaisson RE, Dorman SE, Nahid P, Nguyen NV |
| Corporate Authors: |
AIDS Clinical Trials Group A5349, Tuberculosis Trials Consortium Study 31 |
| Source: |
Emerging infectious diseases [Emerg Infect Dis] 2025 Mar; Vol. 31 (3), pp. 467-476. |
| Publication Type: |
Journal Article; Randomized Controlled Trial |
| Journal Info: |
Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
